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Objectives We sought to determine the circadian, weekly, and seasonal variation of coronary stent
thrombosis.
Background Other adverse cardiovascular events such as acute myocardial infarction are known to
have higher incidences during the early morning hours, Mondays, and winter months.
Methods The Mayo Clinic Percutaneous Coronary Intervention Registry was searched for patients
admitted to our center who underwent repeat percutaneous coronary intervention in a previously
stented coronary artery segment. Stent thrombosis was conﬁrmed by angiographic review, and date
and time of symptom onset were obtained from medical records.
Results We identiﬁed 124 patients with deﬁnite stent thrombosis and known date and time of
symptom onset. In these patients, onset of stent thrombosis was signiﬁcantly associated with time
of day (p  0.006), with a peak incidence around 7:00 AM. When patients were subdivided into early
tent thrombosis (0 to 30 days; n  49), late stent thrombosis (31 to 360 days; n  30), and very
late stent thrombosis (360 days; n  45), only early stent thrombosis remained signiﬁcantly associ-
ated with time of day (p  0.030). No association with the day of the week was found (p  0.509);
however, onset of stent thrombosis did follow a signiﬁcant seasonal pattern, with higher occur-
rences in the summer (p  0.036).
Conclusions Coronary stent thrombosis occurs more often in the early morning hours. Early stent
thrombosis follows a circadian rhythm with a peak at 7:00 AM. This pattern was not signiﬁcant in late
nd very late stent thrombosis. Occurrences throughout the week were equally distributed, but
tent thrombosis was more likely to occur in the summer months. (J Am Coll Cardiol Intv 2011;4:
83–90) © 2011 by the American College of Cardiology Foundation
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184Twenty-four-hour (circadian) patterns are present in nu-
merous physiological processes. Circadian variation with a
morning peak has been found in heart rate, blood pressure,
(1,2) and levels of multiple hormones such as renin, aldo-
sterone, and cortisol (3,4). It is becoming increasingly clear
that adverse events follow circadian patterns as well. Circa-
dian variation with a peak in the morning has been observed
in stroke (5), unstable angina pectoris (6), acute myocardial
infarction (AMI) (7,8), and sudden cardiac death (7,9). In
addition, weekly patterns with a peak on Monday and
seasonal patterns with a peak in the winter have been
reported in AMI (10–12) and sudden cardiac death (13,14).
Most of these temporal patterns seem to be attributable to
triggering factors, such as hemodynamic and hemostatic
changes, physical exertion, and mental stress (15–18).
In theory, it is likely that coronary stent thrombosis also
follows a circadian pattern, due to an increased tendency
toward thrombosis in the morning hours (18–20). How-
ever, this hypothesis has only been confirmed by 1 report
with a sample size of 21 patients (21). Furthermore, the role
of triggering factors in stent thrombosis onset has been
suggested in a case report (22). More insight in patterns of
onset of stent thrombosis and
potential triggers might help to
prevent stent thrombosis by op-
timizing medical treatment dur-
ing high-risk intervals through-
out the day, week, and year.
To address the hypothesis that
stent thrombosis follows a circa-
dian pattern, we performed an
analysis of the Mayo Clinic Per-
cutaneous Coronary Intervention Registry. Second, we as-
sessed weekly and seasonal patterns and characterized potential
triggering events preceding stent thrombosis onset.
Methods
Study design. After obtaining institutional review board
pproval, a retrospective analysis was performed, with the
ayo Clinic Percutaneous Coronary Intervention Registry.
his database includes baseline, procedural, angiographic,
nd outcome data on all patients undergoing percutaneous
oronary intervention (PCI) at the Mayo Clinic, Rochester,
innesota. For this registry, data are prospectively collected
y experienced interventional cardiology data technicians.
he database supervisor performs routine audits of 10% of
he records for quality control purposes. We identified
atients admitted to our center who had undergone a
epeated PCI procedure in a coronary artery segment where
stent had been previously placed and who had experienced
udden onset or worsening of anginal symptoms within 1
eek of this repeated PCI procedure. The later criterion was
Abbreviations
and Acronyms
AMI  acute myocardial
infarction
IQR  interquartile range
MET  metabolic equivalent
PCI  percutaneous
coronary interventionetermined by medical record review. We excluded patientsith unknown symptom onset date and time and patients
ho had previously declined to have their medical records
eviewed for research, as is required by Minnesota state law.
e did not study patients with sudden death, because
ngiographic evidence of stent thrombosis could not be
btained in these patients. Subsequently, angiograms of
ligible study subjects were reviewed for angiographic evi-
ence of stent thrombosis by experienced interventional
ardiology trainees blinded to the primary outcome of this
tudy. Thus, the subjects we identified by means of this
ethod have definite stent thrombosis according to the
cademic Research Consortium definition: “an acute coro-
ary syndrome with angiographic or autopsy evidence of
hrombus or occlusion” (23). In addition, medical records
ere reviewed for level of physical activity before symptom
nset, and other events that had potentially triggered stent
hrombosis were identified.
Deﬁnitions. In accordance with the Academic Research
onsortium definition, stent thrombosis was subdivided
nto early stent thrombosis (0 to 30 days), late stent
hrombosis (31 to 360 days), and very late stent thrombosis
360 days) (23). Multivessel disease was defined as the
umber of vessels wherein the first had at least 70% stenosis
nd subsequent vessels had at least 50% stenosis. For the
ndex procedure (initial stent placement), lesion dissection
as defined as the presence of an intimal tear during the
rocedure, regardless of its persistence after completion of
he procedure; and stent size was defined as the smallest
iameter of any stent placed in the coronary artery segment
here stent thrombosis would later occur. Finally, arterial
alcification and lesion calcification were defined as any
isible calcium during coronary angiography. The level of
hysical activity before stent thrombosis symptom onset was
raded with metabolic equivalents (METs). One MET was
efined as the energy spent/minute by a subject sitting
uietly and is equivalent to 3.5 ml of oxygen uptake/
ilogram of body weight/minute by a 70-kg adult (15). This
ethod has previously been used in studies assessing phys-
cal activity as a potential trigger of myocardial infarction
15,17). We defined the categories: sleeping (1 MET), lying
r sitting (1 to 2 METs), light to moderate exertion (3 to 5
ETs), and heavy exertion (6 METs). Furthermore, we
eviewed medical records for other potential triggers of stent
hrombosis. This included documented medication non-
ompliance and patients who were initially admitted to our
enter for other medical conditions but developed stent
hrombosis during their hospital stay. Patients who were
dmitted for stent thrombosis but were found to have other
mportant medical conditions at admission (e.g., infection)
ere also considered to have a potential triggering factor for
tent thrombosis.
Statistical analysis. Continuous variables are summarized as
mean  SD, unless otherwise specified. Discrete variables
are presented as fractions and percentages. Group differ-
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185ences for categorical variables were tested with Pearson
chi-square test. The distribution of time of symptom onset
over the 24-h clock, week, and year were tested against the
null hypothesis of a uniform likelihood with the Rayleigh
test (24). For weekly and seasonal patterns, hour of week
and day of year were used, respectively. To help identify the
average temporal trends, sinusoidal functions were used to
model stent thrombosis as functions of the time of symptom
onset over the day, week, and year. The 4 degrees of
freedom sinusoid consisted of 1-period cosine, 1-period
sine, 2-period cosine, and 2-period sine variables. A 2-tailed
p value 0.05 was considered significant. All analyses were
conducted with SAS 9.1.3 and JMP 8.0 (SAS Institute,
Cary, North Carolina).
Results
Patient population. One thousand six hundred thirty-one
atients with a repeat intervention in a previously stented
oronary artery segment were identified. In 252 patients, the
nset of ischemic symptoms was within 1 week of interven-
ion, and symptom onset date and time could be obtained
rom the medical record. After angiographic review, 124
atients with definite stent thrombosis were identified. The
ther patients were found to have restenosis rather than
tent thrombosis. Index procedures were performed be-
ween February 21, 1995 and June 23, 2009. Subsequent
rocedures for stent thrombosis were performed between
ebruary 22, 1995 and August 20, 2009. Baseline clinical
nd procedural characteristics at the time of the index
rocedure are shown in Table 1. Unless otherwise specified,
he procedural data relate to the coronary artery segment
here stent thrombosis would later occur. Note that 33% of
atients were diabetic, 19% of patients had peripheral
ascular disease, and 15% of patients had an ongoing
alignancy or a history of malignancy in the past 5 years.
urthermore, after the index procedure, dissection of the
oronary artery segment where stent thrombosis would later
ccur was present in 16% of patients.
Temporal variation. Stent thrombosis occurred after a me-
ian of 97 days of initial stent placement, with an inter-
uartile range (IQR) of 4 to 862 days. The patient sample
ncluded 49 patients with early stent thrombosis (median 3
ays after index procedure; IQR: 1 to 5 days), 30 patients
ith late stent thrombosis (median 116 days; IQR: 77 to
16 days), and 45 patients with very late stent thrombosis
median 38 months; IQR: 26 to 63 months).
The primary outcome, stent thrombosis as a function of
4-h circadian time, is shown in Figure 1. We found a
ignificant association between the onset of stent thrombo-
is and time of day, with a low incidence at approximately
:00 PM and a peak at approximately 7:00 AM (p  0.006).
owever, when patients were subdivided into early, late,nd very late stent thrombosis, only the association betweenTable 1. Patient Characteristics During Index Procedure (n  124)
Clinical
Age (yrs) 62.7 13.4
Male 88/124 (71)
Body mass index (kg/m2) 29.5 5.4 (n 123)
Systolic blood pressure (mm Hg) 126.6 26.7 (n 60)
Heart rate (beats/min) 69.5 12.4 (n 60)
Hypertension 83/115 (72)
Hypercholesterolemia 93/116 (80)
Diabetes 40/121 (33)
Current smoker 39/119 (33)
CHF on presentation 13/113 (12)
Peripheral vascular disease 22/118 (19)
Malignancy 18/119 (15)
Metastatic malignancy 2/119 (1.7)
Family history of CAD 37/83 (45)
Prior PTCA 46/124 (37)
Prior myocardial infarction
Single 60/121 (50)
Multiple 27/121 (22)
Prior coronary artery bypass grafting 36/121 (30)
Procedural
Pre-procedural TIMI ﬂow grade
0 13/86 (15)
1 4/86 (4.7)
2 8/86 (9.3)
3 61/86 (71)
Procedure-related vessel*
Left anterior descending artery 40/124 (32)
Right coronary artery 41/124 (33)
Left circumﬂex artery 23/124 (19)
Left main artery 4/124 (3.2)
Vein graft 19/124 (15)
Bifurcation lesion 14/108 (13)
Calcium in stenosis 27/98 (28)
Calcium in artery 34/90 (38)
Dissection 18/114 (16)
Post-procedural TIMI ﬂow grade
2 3/111 (2.7)
3 108/111 (97)
Stent
Type of stent
Drug-eluting stent 45/124 (36)
Bare-metal stent 79/124 (64)
Stent diameter (mm) 3.2 0.6 (n 123)
Total number of stents
1 65/124 (52)
2 38/124 (31)
2 21/124 (17)
All procedural and stent data relate to the coronary artery segment where stent thrombosis
would later occur, except “total number of stents,” which relates to the index procedure as a
whole. Values are mean SD or n/total n (%). *Total % is100%, because 3 patients had stent
thrombosis in 2 vessels.
CAD coronary artery disease; CHF congestive heart failure; PTCA percutaneous translu-
N
o
a
t
o
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 2 , 2 0 1 1
F E B R U A R Y 2 0 1 1 : 1 8 3 – 9 0
Mahmoud et al.
Circadian Variation in Stent Thrombosis
186early stent thrombosis and time of day remained significant
(p 0.030, p 0.537, and p 0.096, respectively) (Figs. 2–4).
o significant association between stent thrombosis symptom
nset and day of week was found (p  0.509). When looking
t seasonal patterns, there were higher stent thrombosis rates in
he summer months, with a peak occurrence between the end
f July and the beginning of August (p  0.036) (Fig. 5).
Procedure indication and medication use. Pre-procedural
medication use and indication for the index and stent
thrombosis procedures are presented in Table 2. Two-thirds
of the patients with stent thrombosis presented with myo-
cardial infarction, most commonly ST-segment elevation
myocardial infarction. Overall, 96% of patients were taking
aspirin at the time of stent thrombosis. Approximately 89%
of patients with early stent thrombosis were taking clopi-
dogrel or ticlopidine, but less than one-half of the patients
with late or very late stent thrombosis used these medica-
tions. When subdivided by type of stent, 86% of patients
with a bare-metal stent and early stent thrombosis were
using clopidogrel or ticlopidine before onset of stent throm-
bosis. This rate was 7 of 20 (35%) for patients with a
bare-metal stent and late stent thrombosis and 6 of 25
(24%) for patients with a bare-metal stent and very late stent
Figure 1. Circadian Variation of Overall Stent Thrombosis (n  124)
The spokes are drawn from the center of the circle to the number of stent
thrombosis events that occurred that hour of the day; the spoke angles
represent the time of day (rounded to the nearest hour). The scale is pre-
sented by concentric circles; the center of the circles represents 0 fre-
quency; and the outer circle represents 12 stent thrombosis events. The
dashed line is a sinusoidal smoothing function indicating the average cir-
cadian trends. The plot indicates that there was a low incidence of stent
thrombosis at approximately 7:00 PM to 12:00 AM and a peak incidence at
approximately 7:00 AM. The association between onset of stent thrombosis
and time of day was signiﬁcant (p  0.006).thrombosis. In patients with a drug-eluting stent, 14 of 15patients (93%) presenting with early stent thrombosis were
using clopidogrel (none of the patients were taking ticlopi-
dine). This rate was only 6 of 10 (60%) for patients with a
drug-eluting stent and late stent thrombosis and 8 of 20
(40%) in patients with a drug-eluting stent and very late
stent thrombosis.
Figure 2. Circadian Variation of Early Stent Thrombosis (n  49)
An explanation of the ﬁgure is provided in the legend of Figure 1. The plot
shows a signiﬁcant association between early stent thrombosis and time of
day (p  0.030). A peak can be appreciated at approximately 7:00 AM.
Figure 3. Circadian Variation of Late Stent Thrombosis (n  30)
An explanation of the ﬁgure is provided in the legend of Figure 1. No sig-
niﬁcant association between late stent thrombosis and time of day was
found (p  0.537).
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187Potential triggers. In 62 patients, activity level before stent
thrombosis symptom onset was documented in their med-
ical record. Twenty-one (33.9%) patients were sleeping (1
MET), 16 (25.8%) patients were lying or sitting (1 to 2
METs), 18 (29.0%) patients were engaged in light-to-
moderate physical exertion (3 to 5 METs), and 7 (11.3%)
patients were engaged in heavy physical exertion (6
METs). We did not find significant differences in physical
activity level among patients with early, late, and very late
stent thrombosis. Furthermore, we identified other medical
conditions that might have triggered stent thrombosis.
These are presented in Table 3. In 5.6% of patients,
medication noncompliance was explicitly documented. Fur-
thermore, 4% of patients were hospitalized for surgery or
invasive diagnostics and developed stent thrombosis during
this hospital stay. Finally, it is important to note that 4% of
patients were found to have either pneumonia or a urinary
tract infection at admission to our center.
Discussion
Although the incidence of stent thrombosis decreased in
recent years due to dual antiplatelet therapy and improved
stent design, the consequences of stent thrombosis are often
severe. Most patients that experience stent thrombosis die
or suffer AMI (25). In the present study, we demonstrated
on a continuous scale that stent thrombosis follows a cir-
cadian rhythm with a peak at 7:00 AM. This circadian
Figure 4. Circadian Variation of Very Late Stent Thrombosis (n  45)
An explanation of the ﬁgure is provided in the legend of Figure 1. No sig-
niﬁcant association between very late stent thrombosis and time of day
was found (p  0.096). There was, however, a trend toward a higher inci-
dence of stent thrombosis between 6:00 AM and 12:00 PM.rhythm might be absent or less-pronounced in late and verylate stent thrombosis. Furthermore, we found a significant
association between stent thrombosis and season with a
peak in the summer months. No weekly pattern in stent
thrombosis onset was found.
Several physiological processes might contribute to the
increased incidence of stent thrombosis in the morning.
First, renin-angiotensin-aldosterone system activity is in-
creased between 6:00 AM and 8:00 AM, (3) thus causing
igher blood pressure and heart rate in the morning (1,2).
his might trigger stent thrombosis by causing shear stress.
econd, blood viscosity tends to be higher in the morning,
nd this might be magnified by assuming the upright
osture after a night of supine sleep (26). Higher blood
iscosity in combination with higher vascular tone (27)
akes the occurrence of symptomatic stent thrombosis
ore likely in the morning. Third, patients might have
uffered from coronary spasm, which has been associated
ith thrombus formation (28) and mainly occurs during the
ight and in the morning (29). Fourth, a hypercoagulable
nd hypofibrinolytic state might be responsible for the
orning excess in cardiovascular events. Tofler et al. (20)
eported increased platelet aggregability. Furthermore, An-
reotti et al. (19) demonstrated that tissue-type plasmino-
en activator, the major component of the fibrinolytic
ystem, was reduced in the morning, reaching lowest values
t 6:00 AM. At the same time, the activity of the fast-acting
nhibitor of fibrinolysis, plasminogen activator inhibitor,
as increased. Finally, antithrombotic medication such as
spirin, clopidogrel, and ticlopidine are likely to have nadir
Figure 5. Incidence of Stent Thrombosis Throughout the Year (n  124)
There was a signiﬁcant association between stent thrombosis onset and
day of year (p  0.034). Higher rates of stent thrombosis were found in the
summer months, reaching peak incidences in July and August.
 ST-se
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188levels in the morning, just before the patient wakes up and
takes a new dose.
Our study confirms a previous report on circadian varia-
tion in stent thrombosis. To our knowledge, there has only
been 1 prior study that assessed circadian variation of stent
thrombosis in a group of 21 patients (21). Tamura et al.
found a higher morning incidence of subacute stent throm-
bosis in patients with a bare-metal stent. However, this
study used 6-h intervals and did not assess weekly and
seasonal patterns due to a limited sample size.
In addition to a circadian variation, we found a higher
occurrence of stent thrombosis in the summer months. An
Table 2. Indication for the Procedure and Pre-Proced
Index Procedure (n  124)
Indication for the procedure
Unstable angina 65/124 (52)
STEMI 28/124 (23)
NSTEMI 18/124 (15)
Positive exercise test 6/124 (4.8)
Arrhythmia 1/124 (0.8)
Chronic heart failure 2/124 (1.6)
Asymptomatic 1/124 (0.8)
Other 3/124 (2.4)
Pre-procedural medication
Aspirin 113/118 (96)
Beta blocker 101/119 (85)
Clopidogrel 29/105 (28)
Ticlopidine 3/119 (2.5)
Anticoagulant 4/118 (3.4)
Values are n/total n (%). The p values are index procedure versus over
NSTEMI non–ST-segment elevation myocardial infarction; STEMI
Table 3. Potential Triggers and Risk Factors for Stent Thrombosis
(n  124)
Pharmacological triggers
Medication noncompliance 7/124 (5.6)
Hospital admission for other problems
Surgery/invasive diagnostics 5/124 (4.0)
Pneumonia* 4/124 (3.2)
Current chemotherapy/radiotherapy 2/124 (1.6)
Urinary tract infection 1/124 (0.8)
Pulmonary embolism 1/124 (0.8)
Stroke 1/124 (0.8)
Onset during hemodialysis 1/124 (0.8)
Onset during adenosine sestamibi 1/124 (0.8)
Factor V Leiden 3/124 (2.4)
History of chest radiation 1/124 (0.8)
Total potential triggers/risk factors† 27
Number of patients with potential triggers/risk factors 26/124 (21)Values are n/total n (%). *1 being possible pneumonia; †1 patient had 2 potential triggers.intuitive explanation might be that patients were more
active in the warm months of the year compared with the
cold months. However, most reports assessing seasonal
patterns in AMI find higher incidences in the winter
months (10,11). Still, even passive heating in the summer
can cause sympathetic nervous system activation and in-
creased heart rate and thus might explain higher stent
thrombosis rates in the summer (30,31).
We did not find a significant association between onset of
stent thrombosis and day of the week. In other cardiovas-
cular conditions, such as AMI, higher occurrences have
been found on Monday (11,12). It is likely that mental
stress accounts for this pattern, because it is less pronounced
in the nonworking population. The absence of this pattern
in stent thrombosis might suggest a more limited role of
mental stress as a triggering factor for stent thrombosis.
When we looked at the baseline characteristics of our
patients, high rates of diabetes, peripheral vascular disease,
malignancy, and dissection were found. These conditions
have been shown to be independent risk factors for stent
thrombosis in a study by van Werkum et al. (32). We tried
to establish physical activity level and other potential trig-
gers for stent thrombosis onset, in addition to these data.
Although there is a great body of evidence with regard to
the role of triggers in onset of AMI and sudden cardiac
death, this is not the case for stent thrombosis. We had
several important findings. First, we found that stent
thrombosis was preceded by heavy physical exertion in
11.3% of patients. Most patients, however, were either
asleep or performing light exercise. In a recent report
edication Use
Stent Thrombosis
p Value(n  49) Late (n  30) Very Late (n  45)
49 (39) 15/30 (50) 5/45 (11)
49 (47) 11/30 (37) 27/45 (60)
49 (12) 3/30 (10) 12/45 (27)
1/30 (3.3)
49 (2.0) 1/45 (2.2)
48 (100) 29/30 (97) 41/45 (91) 0.968
48 (85) 24/29 (83) 39/45 (87) 0.978
44 (77) 13/30 (43) 14/45 (31) 0.0001
44 (11) 0.494
49 (14) 1/29 (3.5) 1/45 (2.2) 0.254
thrombosis procedure.
gment elevation myocardial infarction.ural M
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189physical exertion was suggested (22). Our results show that
there is indeed circumstantial evidence that heavy physical
exertion might play a role in stent thrombosis onset. Surely,
it is unlikely that 11% of a population is engaged in heavy
physical activity at a certain point. More research on this
topic is warranted to confirm our findings and estimate the
size of this risk factor. Previous studies using the case-
crossover design have identified heavy physical exertion as a
risk factor for AMI (15,17). Second, 4% of patients were
hospitalized for surgery or invasive diagnostics. These con-
ditions might have interfered with the antithrombotic
medication regimen, thus causing stent thrombosis. Third,
in 5.6% of patients, medication noncompliance was explic-
itly documented. However, we found that a much larger
proportion of patients did not use clopidogrel or ticlopidine
for at least 30 days (2007 guideline) or 1 year (current
guideline) after implantation of a bare-metal stent or for at
least 1 year after implantation of a drug-eluting stent, as is
recommended by the American College of Cardiology/
American Heart Association guidelines (33,34). Fourth,
approximately 4% of patients had an ongoing acute infec-
tion before stent thrombosis onset. Acute infections, par-
ticularly in the respiratory and urinary tract, might well be
triggers of stent thrombosis, because they have shown to
increase the risk of other adverse cardiovascular events as
well (35–37). For instance, a large study in the U.K.
demonstrated an increased risk of AMI and stroke in
patients with a respiratory tract infection (including pneu-
monia) or a urinary tract infection (36). Finally, we found
factor V Leiden in 2.4% of our patients. Although factor V
Leiden is a well-known risk factor for venous thrombosis,
we did not find a higher prevalence of this condition in our
patient sample compared with the general population (ap-
proximately 6%) (38,39). In addition, multiple reports have
suggested that factor V Leiden is not associated with arterial
thrombosis (38,40).
Study limitations. Given the number of theoretical mecha-
isms for circadian rhythms but the modest number of
atients reported, analysis of associations must be regarded
s speculative. Although we used prospectively collected
ata, this was a retrospective analysis. Because date and time
f symptom onset were unavailable in some patients, our
ample does not consist of consecutive patients. Also, data
vailability did not allow us to identify patients who had
ndergone a single index or stent thrombosis procedure at
ur center and the other procedure at another center.
owever, we believe lack of data was completely random
nd was unlikely to have biased our analysis. Furthermore,
ecause stent thrombosis is a relatively rare complication,
ur sample size was limited. Therefore, this study might not
ave had enough statistical power to demonstrate circadian
ariation in late and very late stent thrombosis. That we did
ot find a weekly pattern could also be due to limited power.
nother limitation is that we did not study patients withudden death. We recognize that stent thrombosis often
eads to death (25), but we chose not to include these
atients, because angiographic evidence of stent thrombosis
ould not be obtained. Another reason is that the well-
stablished circadian rhythm of sudden cardiac death (7,9)
ould pose a potential source of bias in our analysis.
owever, exclusion of sudden deaths might account for the
emarkable seasonal distribution we found. It might be
ossible that stent thrombosis is more severe during the
inter and thus causes more sudden deaths. Finally, we did
ot include a control group in our analysis of potential
riggers of stent thrombosis. Therefore, statements made
egarding potential triggers could not be tested, and this
art of our analysis should be seen as merely explorative.
onclusions
This study shows that: 1) stent thrombosis follows a
circadian rhythm with an early morning peak; 2) stent
thrombosis follows a seasonal rhythm with a peak in the
summer; and 3) potential triggers of stent thrombosis can be
identified in a considerable number of patients—mainly
exercise and conditions or behavior that interfere with an
optimal medication regimen.
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